Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Médiation du système nerveux sympathique des effets aigus de l'exercice sur le cerveau et la cognition de l'enfant

16 novembre 2026 mis à jour par: Chuck Hillman, Northeastern University

Today's children have become increasingly inactive and unfit, with >50% of children not meeting the recommended 60 min of moderate-to-vigorous physical activity. Previous research has suggested that acute aerobic exercise of moderate intensity was associated with improved cognition manifested by improved performance and increased P3 amplitude, a neuroelectric indicator that reflects the amount of attentional allocation, in tasks requiring cognitive control. While minimal evidence exists to support potential mechanisms underlying the transient effects of exercise on brain and cognition, research suggests that phasic changes in the locus coeruleus-norepinephrine (LC-NE) (as measured by salivary alpha amylase (sAA)) system are a potential mechanism for explaining the acute effect of exercise on brain and cognition. Accordingly, the aim of this study is to examine the mechanisms linking acute aerobic exercise to improved cognitive control as well as the underlying neuroelectrical activities in children, using electroencephalography (EEG) and event-related potentials (ERPs). We hope to gain a better understanding of the role of acute exercise and cognitive and brain health. The results from this study will help identify mechanisms linking acute exercise to enhanced cognitive performance in children.

Our hypothesis is that exercise-induced phasic increases in sympathetic nervous system activity will mediate the effect of a single bout of exercise on brain function, cognition, and standardized achievement test performance.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Réel)

104

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Massachusetts
      • Boston, Massachusetts, États-Unis, 02115
        • Northeastern University

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

9 ans à 10 ans (Enfant)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Parental/guardian consent (non-consent of guardian).
  • Participants must have had no prior diagnosis of cognitive or physical disability, including attention deficit hyperactivity disorder (severe asthma, epilepsy, chronic kidney disease, and dependence upon a wheelchair/walking aid).
  • Participants must be free of any type of anti-psychotic, anti-depressant, anti-anxiety medication, as well as those medications used for attention deficit hyperactivity disorder (use of any anti-psychotic, anti-depressant, anti-anxiety, and attention deficit hyperactivity disorder medications).
  • Normal or corrected-to-normal vision based on the minimal 20/20 standard in order to complete the cognitive task (below 20/20 vision).
  • Participants must have not yet reached, or be in the earliest stages, of puberty, as measured by a modified test of the Tanner Staging System (onset of puberty as determined by Tanner).
  • English speaking.

Exclusion Criteria:

  • Participants with an intelligence quotient below 85 will be excluded.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Science basique
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation croisée
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Aerobic Exercise Intervention

The protocol will include a 25-min bout of exercise at an intensity of 75% HRmax, such that participants will engage in a 1- min warm up and a 1-min cool down, with the majority of time (i.e., 23-min) spent exercising at 75% of HRmax.

Participants will be asked to imagine that they are in a new class with 20 other students, and that their teacher has asked them to stand in front of the class and introduce themselves. The mental arithmetic task will entail asking children to serially subtract the number 5 from a larger number as quickly as possible.

Participants will sit in a comfortable chair, placed in the same room as the motor-driven treadmill, for a period of 25-min. They will be asked to sit quietly or read a book of their choosing.

Comparateur actif: Trier Social Stress Test for Children (TSST-C)

Participants will be asked to imagine that they are in a new class with 20 other students, and that their teacher has asked them to stand in front of the class and introduce themselves. The mental arithmetic task will entail asking children to serially subtract the number 5 from a larger number as quickly as possible.

Participants will sit in a comfortable chair, placed in the same room as the motor-driven treadmill, for a period of 25-min. They will be asked to sit quietly or read a book of their choosing.

The protocol will include a 25-min bout of exercise at an intensity of 75% HRmax, such that participants will engage in a 1-min warm up and a 1-min cool down, with the majority of time (i.e., 23-min) spent exercising at 75% of HRmax.

Comparateur placebo: Seated Rest

Children will be asked to sit quietly or read a book of their choosing. Participants will sit in a comfortable chair, placed in the same room as the motor-driven treadmill, for a period of 25-min.

Participants will be asked to imagine that they are in a new class with 20 other students, and that their teacher has asked them to stand in front of the class and introduce themselves. The mental arithmetic task will entail asking children to serially subtract the number 5 from a larger number as quickly as possible.

The protocol will include a 25-min bout of exercise at an intensity of 75% HRmax, such that participants will engage in a 1-min warm up and a 1-min cool down, with the majority of time (i.e., 23-min) spent exercising at 75% of HRmax.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Salivary Alpha Amylase (sAA) Response to Interventions
Délai: Upon arrival (T1), before (T2) and after (T3) baseline cognitive task, after intervention (T4), before (T5) and after (T6) post-intervention cognitive task, after academic achievement test (T7); up to 2.5 hours per visit, 3 visits

each participant's sAA was compared across all three interventions for a within subject design. Each day sAA was collected at multiple timepoints.

Upon arrival (T1), before (T2) and after (T3) baseline cognitive task, after intervention (T4), before (T5) and after (T6) post-intervention cognitive task, after academic achievement test (T7); up to 2.5 hours per visit, 3 visits
Cortisol (CORT) Response to Interventions
Délai: Upon arrival (T1), before (T2) and after (T3) baseline cognitive task, after intervention (T4), before (T5) and after (T6) post-intervention cognitive task, after academic achievement test (T7); up to 2.5 hours per visit, 3 visits

Each participant's CORT was compared across all three interventions for a within subject design. Each day CORT was collected at multiple timepoints.

Upon arrival (T1), before (T2) and after (T3) baseline cognitive task, after intervention (T4), before (T5) and after (T6) post-intervention cognitive task, after academic achievement test (T7); up to 2.5 hours per visit, 3 visits

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

10 février 2019

Achèvement primaire (Réel)

30 juin 2024

Achèvement de l'étude (Réel)

30 juin 2024

Dates d'inscription aux études

Première soumission

12 juin 2018

Première soumission répondant aux critères de contrôle qualité

9 juillet 2018

Première publication (Réel)

19 juillet 2018

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

16 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 1R01HD094054-01 (Subvention/contrat des NIH des États-Unis)
  • R01HD094054 (Subvention/contrat des NIH des États-Unis)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

INDÉCIS

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner